Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2015

Mar 25, 2015

33819_dirs_2015-03-25_88e397da-2e71-4080-a60d-def3d5e538fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2015-03-23

Reporting Person: Massey Ian J (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-23 Common Stock A 750000 $0.00 Acquired 750000 Direct

Footnotes

F1: Restricted stock units with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical studies in dry AMD and spinal cord injury.

F2: Consists of 750,000 restricted stock units with performance based vesting.